Current Net Margin
22.80%
4D Molecular Therapeutics, Inc. currently has a net profit margin of 22.80%.
Financial Fundamentals
FDMT • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.09 | 0.02 | 22.80% | ▲6321835 |
| 2025-09-30 | 0.00 | -0.06 | -63195.56% | ▲30119111 |
| 2025-06-30 | 0.00 | -0.05 | -364386.67% | ▼2172952 |
| 2025-03-31 | 0.00 | -0.05 | -342657.14% | ▲462444286 |
| 2024-12-31 | 0.00 | -0.05 | -4967100.00% | ▼350566667 |
| 2024-09-30 | 0.00 | -0.04 | -1461433.33% | ▼76237333 |
| 2024-06-30 | 0.00 | -0.03 | -699060.00% | ▼58334214 |
| 2024-03-31 | 0.00 | -0.03 | -115717.86% | ▼28562838 |
| 2023-12-31 | -0.00 | -0.03 | 169910.53% | ▲16996129 |
| 2023-09-30 | 0.02 | -0.01 | -50.76% | ▲1234087 |
| 2023-06-30 | 0.00 | -0.03 | -12391.63% | ▼276680 |
| 2023-03-31 | 0.00 | -0.03 | -9624.83% | ▼742924 |
| 2022-12-31 | 0.00 | -0.03 | -2195.59% | ▲294261 |
| 2022-09-30 | 0.00 | -0.03 | -5138.20% | ▲1219884 |
| 2022-06-30 | 0.00 | -0.03 | -17337.04% | ▼1517641 |
| 2022-03-31 | 0.00 | -0.03 | -2160.62% | ▲2510351 |
| 2021-12-31 | 0.00 | -0.03 | -27264.13% | ▼2563609 |
| 2021-09-30 | 0.00 | -0.02 | -1628.04% | ▼157599 |
| 2021-06-30 | 0.01 | -0.01 | -52.05% | ▲76825 |
| 2021-03-31 | 0.00 | -0.02 | -820.30% | ▼292337 |
| 2020-12-31 | -0.00 | -0.02 | 2103.07% | ▲220862 |
| 2020-09-30 | 0.01 | -0.01 | -105.55% | ▲31154 |
| 2020-06-30 | 0.00 | -0.02 | -417.09% | ▼4482 |
| 2020-03-31 | 0.00 | -0.01 | -372.28% | ▲42157 |
| 2019-12-31 | 0.00 | -0.02 | -793.84% | ▲229412 |
| 2019-09-30 | 0.00 | -0.02 | -3087.96% | ▼271396 |
| 2019-06-30 | 0.00 | -0.01 | -374.00% | 0 |
| 2019-03-31 | 0.00 | -0.01 | -374.00% | ▼32583 |
| 2018-12-31 | 0.00 | -0.00 | -48.17% | 0 |
| 2018-09-30 | 0.00 | -0.00 | -48.17% | ▲5413 |
| 2018-06-30 | 0.00 | -0.00 | -102.31% | 0 |
| 2018-03-31 | 0.00 | -0.00 | -102.31% | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.